Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Syngenta to squeeze out Devgen shares

Syngenta has closed the mandatory reopening of its bid for Belgian biotechnology company Devgen (Ghent) with 98.3% of the shares being tendered. Payment for the shares already tendered will take place on January 30th. As Syngenta has acquired more than 95% of the shares in Devgen, it will proceed with a simplified squeeze-out in order to acquire the remaining shares and warrants. A squeeze-out refers to the compulsory acquisition of the stakes of a small group of shareholders by means of cash compensation. It will take place from February 6th to February 26th and be settled on March 8th. Upon settlement of the squeeze-out, all the shares will have been acquired by Syngenta and become automatically delisted from NYSE Euronext Brussels exchange. The Swiss company announced its intention in September to bid for Devgen ( Agrow No 649, p 3).

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG007140

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel